Publication

B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering

Journal Paper/Review - Oct 1, 2010

Units
PubMed

Citation
Audigé A, Schlaepfer E, von Wyl V, Miller R, Vernazza P, Nadal D, Speck R, SHCS. B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering. AIDS Res Hum Retroviruses 2010; 26:1063-74.
Type
Journal Paper/Review (English)
Journal
AIDS Res Hum Retroviruses 2010; 26
Publication Date
Oct 1, 2010
Issn Electronic
1931-8405
Pages
1063-74
Brief description/objective

Each cell in HIV-associated primary central nervous system lymphoma (PCNSL) harbors latent EBV. Notably, the triggering of TLR9, a key event in HIV pathogenesis, also promotes EBV latency and transformation. We hypothesized that because only a minority of HIV-infected patients develops PCNSL, their B cells exhibit aberrant signaling responses to TLR9 triggering. We found higher levels of IL-6, CD80, and CD86 expression at baseline in B cells of those patients than in B cells of matched controls, whereas TNF-a expression was lower. Notably, on TLR9 triggering with CpG 2006, CD80 and TNF-? were up-regulated to a lesser extent in B cells of the former than in those of matched controls. The reduced up-regulation of CD80 might be explained by its higher baseline expression resulting in a more blunted response rather than a specific deficit of the signaling response to TLR9 triggering. However, this cannot explain the blunted TNF-? response, which warrants further investigation. Finally, since increased IL-6 expression is linked to EBV-associated Hodgkin's lymphoma, the enhanced baseline expression of IL-6 might be important in the pathogenesis of PCNSL in HIV-infected patients.